Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: a prospective population-based study

Baptiste Pignon, Joane Matta, Emmanuel Wiernik, Anne Toussaint, Bernd Loewe, Olivier Robineau, Fabrice Carrat, Gianluca Severi, Mathilde Touvier, Clement Gouraud, Charles Ouazana Vedrines, Victor Pitron, Brigitte Ranque, Nicolas Hoertel, Sofiane Kab, Marcel Goldberg, Marie Zins, Cédric Lemogne

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

Résumé

Background Identifying factors that predict the course of persistent symptoms that occurred during the COVID-19 pandemic is a public health issue. Modifiable factors could be targeted in therapeutic interventions. Objective This prospective study based on the population-based CONSTANCES cohort examined whether the psychological burden associated with incident persistent symptoms (ie, that first occurred from March 2020) would predict having ≥1 persistent symptom 6–10 months later. Methods A total of 8424 participants (mean age=54.6 years (SD=12.6), 57.2% women) having ≥1 incident persistent symptom at baseline (ie, between December 2020 and February 2021) were included. The psychological burden associated with these persistent symptoms was assessed with the Somatic Symptom Disorder-B Criteria Scale (SSD-12). The outcome was having ≥1 persistent symptom at follow-up. Adjusted binary logistic regression models examined the association between the SSD-12 score and the outcome. Findings At follow-up, 1124 participants (13.3%) still had ≥1 persistent symptom. The SSD-12 score at baseline was associated with persistent symptoms at follow-up in both participants with (OR (95% CI) for one IQR increase: 1.42 (1.09 to 1.84)) and without SARS-CoV-2 infection prior to baseline (1.39 (1.25 to 1.55)). Female gender, older age, poorer self-rated health and infection prior to baseline were also associated with persistent symptoms at followup. Conclusions The psychological burden associated with persistent symptoms at baseline predicted the presence of ≥1 persistent symptom at follow-up regardless of infection prior to baseline.

langue originaleAnglais
journalBMJ mental health
Volume27
Numéro de publication1
Les DOIs
étatPublié - 15 mars 2024
Modification externeOui

Contient cette citation